Department of Chemistry Seminar
\n
'Natural Product Dr
ug Discovery @ Eskitis'
Place: Lilla hörsalen\, K
B3A9
Host: Mikael Elofsson
Abstract: Nature has continuously provided the human race with a broad and structurally diverse arsenal of pharmacologically active compounds that h ave been effectively utilised in the treatment of numerous diseases. More than 50% of all marketed drugs in the world are natural products or their derivatives. Well-known examples of valuable natural products used as medi cines today include tacrolimus (immunosuppressant)\, erythromycin (antibio tic)\, paclitaxel (breast/ovarian/lung cancer)\, lovastatin (cholesterol l owering) and galantamine (anti-Alzheimer). Due to the developing resistanc e of many cancer-types\, microbes and parasites\, and the minimal safety a nd efficacy associated with certain drugs on the market today\, there is s till a high demand for the discovery and development of new therapeutics. This talk will detail current biodiscovery efforts being undertaken by the Davis research group at the Eskitis Institute\, Griffith University.
\n
Biosketch: Dr. Rohan Davis obtained his Bachel
or of Science (Hons) from the University of Melbourne in 1992\, with co-ma
jors in organic chemistry and biochemistry. Rohan worked as a research ass
istant on the AstraZeneca/Griffith University Biodiscovery Program (1994–1
996) before undertaking his doctoral studies (1997–2000) at Griffith Unive
rsity in the area of marine organic chemistry under the supervision of Pro
f. Ron Quinn and Prof. Tony Carroll\, A post-doctoral stint at the Univers
ity of Utah with Prof. Chris Ireland was undertaken (2001–2003) before ret
urning to Griffith to set up his research group\, which currently focuses
on the identification and synthesis of bioactive natural products from pla
nts\, fungi and marine invertebrates. This research has resulted in the di
scovery of many new compounds\, some of which have been shown to display p
otent anti-cancer\, anti-bacterial and/or anti-malarial activity. Dr. Davi
s has authored 91 publications in international chemistry/biology journals
\, and currently holds one patent.
Department of Chemistry Seminar
\nRohan Davis\, Eskitis Institute for Cell an
d Molecular Therapies\, Griffith University\, Brisbane\, Australia
'N
atural Product Drug Discovery @ Eskitis'
Place: L
illa hörsalen\, KB3A9
Host: Mikael Elofsson
Abstract: Nature has continuously provided the human race with a broad and structurally diverse arsenal of pharmacologically active compounds that have been effectively utilised in the treatment of numerou s diseases. More than 50% of all marketed drugs in the world are natural p roducts or their derivatives. Well-known examples of valuable natural prod ucts used as medicines today include tacrolimus (immunosuppressant)\, eryt hromycin (antibiotic)\, paclitaxel (breast/ovarian/lung cancer)\, lovastat in (cholesterol lowering) and galantamine (anti-Alzheimer). Due to the dev eloping resistance of many cancer-types\, microbes and parasites\, and the minimal safety and efficacy associated with certain drugs on the market t oday\, there is still a high demand for the discovery and development of n ew therapeutics. This talk will detail current biodiscovery efforts being undertaken by the Davis research group at the Eskitis Institute\, Griffith University.
\n
Biosketch: Dr. Rohan Davis obt
ained his Bachelor of Science (Hons) from the University of Melbourne in 1
992\, with co-majors in organic chemistry and biochemistry. Rohan worked a
s a research assistant on the AstraZeneca/Griffith University Biodiscovery
Program (1994–1996) before undertaking his doctoral studies (1997–2000) a
t Griffith University in the area of marine organic chemistry under the su
pervision of Prof. Ron Quinn and Prof. Tony Carroll\, A post-doctoral stin
t at the University of Utah with Prof. Chris Ireland was undertaken (2001–
2003) before returning to Griffith to set up his research group\, which cu
rrently focuses on the identification and synthesis of bioactive natural p
roducts from plants\, fungi and marine invertebrates. This research has re
sulted in the discovery of many new compounds\, some of which have been sh
own to display potent anti-cancer\, anti-bacterial and/or anti-malarial ac
tivity. Dr. Davis has authored 91 publications in international chemistry/
biology journals\, and currently holds one patent.
The National and International Seminar Series
<
br />Dr. Antoni Hurtado\, Breast Cancer Research group\, Nordic E
MBL Partnership\, Centre for Molecular Medicine Norway\, University of Osl
o\, Norway
“HER2 signalling pathway controls the functions of FOXA1 i
n breast cancer”
Place: Betula Blgd. 6M
<
strong>Host: Sun Nyut Wai\, Molbiol
The National and International Semi
nar Series
Dr. Antoni Hurtado\, Breast Cancer Research
group\, Nordic EMBL Partnership\, Centre for Molecular Medicine Norway\,
University of Oslo\, Norway
“HER2 signalling pathway controls the fun
ctions of FOXA1 in breast cancer”
Place: Betul
a Blgd. 6M
Host: Sun Nyut Wai\, Molbiol
<
/p>
END:VEVENT
BEGIN:VEVENT
UID:20131112T141500UTC-4cc474@http://www.ucmr.umu.se/
DTSTAMP:20260525T215838Z
CATEGORIES:Seminar
DESCRIPTION:
Medical Biochemistry and Biophysics Seminar Series\, autumn 2013
\nGerd Gleixner\, Max-Planck- Institute for Biogeochemistry\, Jena Germany.
\n'Isotopes in Biogeosciences'
\nPlace: Lilla hörsalen K
B3A9\, KBC
Host: Jürgen Schleucher
Medical Biochemistry and Biophysics Seminar Series\, autumn 2013
\nGerd Gleixner\, Max-Planck-Institute for Biogeochemistry\, Jena Germany.
\nPlace:
Lilla hörsalen KB3A9\, KBC
Host: Jürgen Schleucher<
/p>
END:VEVENT
BEGIN:VEVENT
UID:2af5e907938f067ea27eeaa9d0344955http://www.ucmr.umu.se
DTSTAMP:20260525T215838Z
CATEGORIES:Seminar
DESCRIPTION:
The National and International Seminar Series
Prof. Martin Hällberg\, Cell and molecular
biology\, Karolinska Institute\, Sweden and Center for Structural Systems
Biology\, DESY Campus\, Hamburg\, Germany
“Structural basis of RNA bi
ogenesis”
Place: Lecture hall\, Betula\, Blgd.
6M
Host: Anders Byström\, MolBiol
The National and International Semi
nar Series
Prof. Martin Hällberg\, Ce
ll and molecular biology\, Karolinska Institute\, Sweden and Center for St
ructural Systems Biology\, DESY Campus\, Hamburg\, Germany
“Structura
l basis of RNA biogenesis”
Place: Lecture hall
\, Betula\, Blgd. 6M
Host: Anders Byström\, MolBiol<
br />
J. Peter Svensson\, Department of Bioscienc es and Nutrition\, Karolinska Institutet\, Stockholm\, Sweden.
\n
Host:
Nasim Sabouri
J. Peter Svensson\, Depart ment of Biosciences and Nutrition\, Karolinska Institutet\, Stockholm\, Sw eden.
\n'Maintaining centromere activity and integrity'
\nPlace: Stora hörsalen KB3B1\, KBC
The National and International Seminar Series
Prof. Wendy Bickmore\, MRC Human Genetics U
nit\, University of Edinburgh\, Scotland
“Long-range gene regulation
and chromosome folding”
Place: Lecture hall\,
Betula\, Blgd. 6M
Host: Yuri Schwartz\, MolBiol
The National and International Semi
nar Series
Prof. Wendy Bickmore\, MRC
Human Genetics Unit\, University of Edinburgh\, Scotland
“Long-range
gene regulation and chromosome folding”
Place: Lecture hall\, Betula\, Blgd. 6M
Host: Yuri Schwar
tz\, MolBiol